Key points are not available for this paper at this time.
This Editorial discusses the existing policy efforts in the US for ensuring adequate racial and ethnic diversity in clinical trials, identifies barriers to consistency and acceptable representation, and suggests measures to address them.
Varma et al. (Thu,) studied this question.